Business Context and Reporting Period
This Form 8-K filing by Community Health Systems, Inc. (CHS) reports on events occurring on February 27, 2013. The filing details the Board of Directors' approval of compensation arrangements for Named Executive Officers (NEOs), including 2012 incentive payments, 2013 base salaries, and 2013 equity grants. The company operates through its wholly-owned subsidiary, Community Health Systems Professional Services Corporation.
Key Financial Metrics and Compensation Data
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the company. It focuses exclusively on executive compensation figures.
- 2012 Incentive Payments Approved:
- Wayne T. Smith (CEO): $4,200,000 (100% of target)
- W. Larry Cash (CFO): $1,500,000 (100% of target)
- William S. Hussey (Division President): $709,920 (77% of target)
- David L. Miller (Division President): $810,900 (88% of target)
- Michael T. Portacci (Division President): $785,424 (93% of target)
- Thomas D. Miller (Division President): $826,200 (90% of target)
- 2013 Base Salaries (Unchanged since 2011):
- CEO: $1,400,000
- CFO: $750,000
- Division Presidents: Range from $561,000 to $612,000
- 2013 Equity Grants:
- Non-Qualified Stock Options: 0 granted to all NEOs.
- Performance-Based Restricted Shares: CEO received 125,000; CFO received 50,000; Division Presidents received 25,000 each.
Material Changes and Strategic Shifts
Significant changes in compensation structure were noted compared to prior years:
- Equity Mix Adjustment: The company eliminated grants of non-qualified stock options for 2013. This follows a 20% reduction in options and 50% reduction in restricted stock in 2012. The 2013 plan increased Performance-Based Restricted Shares to hold the total share count essentially flat.
- Performance Metrics: The 2013 incentive plans for the CEO and CFO now include a component for relative Total Shareholder Return (TSR) against a peer group. Division Presidents' plans include specific goals for margin improvement and hospital performance.
- Salary Stability: Base salaries for all named executives remained unchanged from 2011 levels.
Guidance, Outlook, and Risks
The filing outlines specific performance hurdles tied to executive compensation rather than providing general corporate guidance:
- 2013 Performance Targets: Restricted stock awards vest only if the company attains either 75% of the low end of the projected EPS range or 90% of the low end of the projected net operating revenues range (as stated in the February 21, 2013 earnings release).
- Non-Financial Criteria: Incentives are also tied to physician recruitment, capital budget adherence, clinical compliance, and volume growth.
- Forfeiture Risk: If performance objectives are not met, the 2013 restricted stock awards will be forfeited in their entirety.
- Employment Agreements: The filing notes that none of the executive officers have written employment agreements.
Investor Verification Checklist
- Verify the specific "low end" ranges for 2013 projected EPS and Net Operating Revenues referenced in the February 21, 2013 Form 8-K earnings release to understand the vesting thresholds.
- Confirm the peer group composition used for the relative Total Shareholder Return (TSR) metric.
- Review the 2012 annual report to compare the total compensation cost impact of the shift from stock options to restricted shares.
- Monitor future filings for actual 2013 performance results to determine if the approved restricted shares will vest or be forfeited.